• About Us
  • Disclaimer for Pledge Times
  • T & C
  • Write To Us
Saturday, April 17, 2021
No Result
View All Result
PledgeTimes
  • World
  • Business
  • Entertainment
  • Gaming
  • Health
  • Lifestyle
  • Science
  • Sports
  • Tech
  • World
  • Business
  • Entertainment
  • Gaming
  • Health
  • Lifestyle
  • Science
  • Sports
  • Tech
No Result
View All Result
PledgeTimes
No Result
View All Result
Home World

Covid-19: Doctor Consultation – How Safe is AstraZeneca’s Covid-19 Vaccine?

by admin
April 8, 2021
in World
0

The European Medicines Agency (EMA) reported a “possible link” between AstraZeneca’s Covid-19 vaccine and some reported clotting cases in people who received the drug. In this context, the UK authorities recommended offering alternative vaccines to those under 30 years of age. In addition, the contagion of people already vaccinated raised new questions. In this Consultation with the Doctor, Dr. Carlos Eduardo PĂ©rez answers these and other questions about vaccines. .
#Covid19 #Doctor #Consultation #Safe #AstraZenecas #Covid19 #Vaccine

Tags: AstraZenecaCovid-19Covid-19: Consultation with the DoctorUnited kingdomVaccines against Covid-19
admin

admin

Next Post

Orange alert for strong storms in the AMBA: what do they recommend to do to reduce risks

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Lauterbach on TV sure: Thromboses with severe courses come from AstraZeneca – ARD viewers worried

1 month ago

In Brazil there are already more deaths than births: the Senate will investigate Jair Bolsonaro for his handling of the covid

3 days ago

Popular News

    Connect with us

    • About Us
    • Disclaimer for Pledge Times
    • T & C
    • Write To Us
    Call us: +1 234 JEG THEME
    No Result
    View All Result
    • Home
    • World
    • Business
    • Science
    • Entertainment
    • Gaming
    • Sports
    • Lifestyle
    • Tech
    • Health

    © 2021 JNews - Premium WordPress news & magazine theme by Jegtheme.